Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan)

Liver International

Volumn 25, Issue 6, 2005, Pages 1162-1168

  Yen, Yi Hao ^a   Chen, Chien Hung ^a   Wang, Jing Houng ^a   Lee, Chuan Mo ^a   Changchien, Chi Sin ^a   Lu, Sheng Nan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Anti HBc; Anti HBe; HBV DNA; Hepatitis B recombinant vaccine; Immune memory; Occult HBV infection

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ADULT; AGE; AGED; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DNA DETERMINATION; DRUG DOSE REGIMEN; DRUG RESPONSE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH PRACTITIONER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TAIWAN; VACCINATION;

ADULT; AGED; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; FEMALE; HEALTH PERSONNEL; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; TAIWAN; VACCINES, SYNTHETIC;

EID: 28944455080     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01157.x     Document Type: Article

References (48)

1. Chen D S, Sung J L. Hepatitis B virus infection and chronic liver diseases in Taiwan. Acta Hepatogastroenterol 1978; 25: 423-30.
2. Stevens C E, Beasley R P, Tsui J J, Lee W C. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292: 771-4.
3. Chen D S, Hsu N H M, Sung J L, Hsu T C, Hsu S T, Kuo Y T, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987; 257: 2597-603.
4. Lee C L, Ko Y C. Hepatitis B vaccination and hepatocellular carcinoma in Taiwan. Pediatrics 1997; 99(3): 351-3.
5. Ni Y H, Chang M H, Huang L M, Chen H L, Hsu H Y, Chiu T Y, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135(9): 796-800.
6. Hadler S C. Vaccines to prevent hepatitis B and hepatitis A virus infections. Infect Dis Clin North Am 1990; 4: 29-46.
7. Zajac B A, West D J, McAleer W J, Scolnick E M. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect 1986; 13(Suppl A): 39-45.
8. Shapiro C N, Margolis H S. Hepatitis B epidemiology and prevention. Epidemiol Rev 1990; 12: 221-7.
9. Stevens C E. Immunoprophylaxis of hepatitis B virus infection. Semin Pediatr Infect Dis 1991; 2: 135-9.
10. West D J. Clinical experience with hepatitis B vaccines. Am J Infect Control 1989; 17: 172-80.
11. Wainwright R B, McMahon B J, Bulkow L R, Parkinson A J, Harpster A P, Hadler S C. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population: preliminary results of an 8-year study. In: Hollinger F B, Lemon S M, Margolis H S, eds. Viral Hepatitis and Liver Disease. Baltimore, MD: Williams & Wilkins, 1991; 762-6.
12. Szmuness W, Stevens C E, Harley E J, Zang E A, Oleszko W R, William D C, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303: 833-41.
13. Hadler S C, Francis D P, Maynard J E, Thompson S E, Judson F N, Echenberg D F, et al. Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986; 315: 209-14.
14. Hadler S C, Coleman P J, O'Malley P, Judson F N, Altman N. Evaluation of long-term protection by hepatitis B vaccine for seven to nine years in homosexual men. In: Hollinger F B, Lemon S M, Margolis H F, eds. Viral Hepatitis and Liver Disease. Baltimore, MD: Williams & Wilkins, 1991; 766-8.
15. Coursaget P, Yvonnet B, Chotard J, Sarr M, Vincelot P, N'doye R, et al. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986; 2: 1143-5.
16. Prinsen H, Goilav C, Safary A, Andre F E, Piot P. Immunogenicity and tolerance of a yeast derived hepatitis B vaccine in homosexual men. Postgrad Med J 1987; 63: 147-9.
17. Wiedermann G, Ambrosch F, Kremsner P, Kunz C, Hauser D, Simoen E, et al. Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine. Postgrad Med J 1987; 63: 109-13.
18. Weber D J, Rutala W A, Samsa G P, Santimaw J E, Lemon S M. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254: 3187-9.
19. Shaw F E, Guess H A, Roets J M, Mohr F E, Coleman P J, Mandel E J, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989; 7: 425-30.
20. Dentico P, Zavoianni A, Volpe A, Buongiorno R, Palma R, Calasso A, et al. Hepatitis B virus infection in hospital staff: epidemiology and persistence of vaccine-induced antibodies. Vaccine 1991; 9: 438-42.
21. Street A C, Weddle T Z, Thomann W R, Lundberg E W, Jackson G W, Hamilton J D. Persistence of antibody in health care workers vaccinated against hepatitis B. Infect Control Hosp Epidemiol 1990; 11: 525-30.
22. Zoulek G, Lorbeer B, Zachoval R, Jilg W, Deinhardt F. Smoking and humoral immune response to hepatitis B vaccine. In: Program and Abstracts of the International Symposium on Viral Hepatitis, San Francisco, CA, 1984; Abstract 9A.26: 142-3.
23. Ukena T, Esber H, Bessette R, Parks T, Crocker B, Shaw F. Site of injection and response to hepatitis B vaccine. N Engl J Med 1985; 313: 579-80.
24. Rogan P D, Duguid J. Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine. J Infect 1991; 22: 5-9.
25. Centers for Disease Control Inadequate immune response among public safety workers receiving intradermal vaccination against hepatitis B - United States, 1990 1991. JAMA 1991; 266: 1338-9 (Originally published in: MMWR Motb Mortal Wkly Rep 1991; 40:569-72).
26. Westmoreland D, Player V, Heap D C, Hammond A. Immunization against hepatitis B: what can we expect? results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B. Epidemiol Infect 1990; 104: 499-509.
27. Andre F E. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med 1989; 87 (Suppl 3A): 14-20S.
28. Chan C Y, Lee S D, Tsai Y T, Lo K J. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol 1995; 10(2): 192-7.
29. Dentico P, Crovari P, Lai P L, Ponzio F, Safary A, Pellegrino A, et al. Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. Vaccine 2002; 20(31-32): 3725-30.
30. Williams I T, Goldstein S T, Tufa J, Tauillii S, Margolis H S, Mahoney F J. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 2003; 22(2): 157-63.
31. Chen D S, Sung J L, Lai M Y. A seroepidemiologic study of hepatitis B virus infection in Taiwan. Taiwan Yi Xue Hui Za Zhi 1978; 77: 908-18.
32. Hadler S C, Murphy B L, Schable C A, Heyward W L, Francis D P, Kane M A. Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigen. J Clin Microbiol 1984; 19: 521-5.
33. Torbenson M, Kannangai R, Astemborski J, Strathdee S A, Vlahov D, Thomas D L. High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 2004; 39(1): 51-7.
34. Ackerman Z, Wands J R, Gazitt Y, Brechot C, Kew M C, Shouval D. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol 1994; 3: 398-404.
35. Sheen I S, Liaw Y F, Chu C M, Pao C C. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis 1992; 165: 831-4.
36. Melegari M, Bruno S, Wands J R. Properties of hepatitis B virus pre-S1 deletion mutants. Virology 1994; 199: 292-300.
37. Seddigh-Tonekaboni S, Waters J A, Jeffers S, Gehrke R, Ofenloch B, Horsch A, et al. Effects of variation in the common, 'a' determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000; 60: 113-21.
38. Altfeld M, Rockstroh J K, Addo M, Kupfer B, Pult I, Will H, et al. Reactivation of hepatitis B in a long term anti-HBs positive patient with AIDS following lamivudine withdrawl. J Hepatol 1998; 29(2): 306-9.
39. Nalpas B, Pourcel C, Feldmann G, Housset C, Tiollais P, Brechot C, et al. Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. J Hepatol 1992; 15(1-2): 118-24.
40. Almroth G, Ekermo B, Mansson A S, Svensson G, Widell A. Detection and prevention of hepatitis C in dialysis patients and renal transplant recipients. A long-term follow up (1989-January 1997). J Intern Med 2002; 251(2): 119-28.
41. Lok A S, Liang R H, Chiu E K, Wong K L, Chan T K, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100(1): 182-8.
42. Chazouilleres O, Mamish D, Kim M, Carey K Ferrell L, Roberts J P, et al. 'Occult' hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343(8890): 142-6.
43. Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 2001; 43(3): 187-90.
44. Chan C Y, Lee S D, Tsai Y T, Lo K J. Hepatitis B vaccination alone is not adequate for the categorizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol 1995; 10(2): 192-7.
45. Centers for Disease Control and Prevention Immunization of healthcare workers: recommendation of the Advisory Committee on Immunization Practices (AICP) and the Hospital Infection Control Advisory Committee (HICPAC). MMWR 1997; 46(RR-18): 1-42.
46. Louther J, Feldman J, Rivera P, Villa N, DeHovitz J, Sepkowitz K A. Hepatitis B vaccination program at a New York City hospital: seroprevalence, seroconversion, and declination. Am J Infect Control 1998; 26(4): 423-7.
47. Perera J, Perera B, Gamage S. Seroconversion after hepatitis B vaccination in healthy young adults, and the effect of a booster dose. Ceylon Med J 2002; 47(1): 6-8.
48. Bauer H, Potasman J, Pick N. I/D hepatitis B vaccination in workers not responsive to I/M vaccination. Harefuah 1998; 134: 441-4.